You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABT-981

Showing 1 - 25 of 377
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa Trial in Worldwide (Lutikizumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Lutikizumab
  • Placebo
  • Phoenix, Arizona
  • +54 more
Jan 26, 2023

Knee Osteoarthritis, Medial Compartment Knee Osteoarthritis Trial (ABT-981, Placebo)

Completed
Has Results
  • Knee Osteoarthritis
  • Medial Compartment Knee Osteoarthritis
  • ABT-981
  • Placebo
  • (no location specified)
Aug 9, 2019

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Healthy Trial in Hachioji (FYU-981, Oxaprozin)

Completed
  • Healthy
  • Hachiōji, Tokyo, Japan
    P-One Clinic
Sep 9, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (TAK-981, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +58 more
Dec 7, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
    A. Brent Carter
Aug 3, 2023

Advanced or Metastatic Solid Tumors Trial in United States (TAK-981, Pembrolizumab)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Scottsdale, Arizona
  • +10 more
Jan 26, 2022

Spinal Cord Injuries, Neurogenic Bladder, Neurogenic Bowel Trial in Vancouver (Transcutaneous Spinal Cord Stimulation, SHAM

Recruiting
  • Spinal Cord Injuries
  • +2 more
  • Transcutaneous Spinal Cord Stimulation
  • +2 more
  • Vancouver, British Columbia, Canada
    Blusson Spinal Cord Centre
Nov 21, 2022

Chronic Spontaneous Urticaria Trial in Dublin (ABT Online Programme, Delayed Control group)

Suspended
  • Chronic Spontaneous Urticaria
  • ABT Online Programme
  • Delayed Control group
  • Dublin, Ireland
    St James's Hospital
Oct 25, 2023

Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

Active, not recruiting
  • Chronic Lymphocytic Leucemia
  • Cologne, Germany
    German CLL Study Group
Sep 14, 2022

Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial in United States (TAK-981, Mezagitamab, Daratumumab and

Recruiting
  • Relapsed and/or Refractory Multiple Myeloma (RRMM)
  • Scottsdale, Arizona
  • +11 more
Jan 6, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +9 more
Jul 8, 2022

Osteoarthritis of Hip Trial in Oswestry (Bioguard Group, Control Group)

Active, not recruiting
  • Osteoarthritis of Hip
  • Bioguard Group
  • Control Group
  • Oswestry, United Kingdom
    RJAH
Jan 24, 2023

Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)

Completed
  • Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +5 more
Jul 11, 2022

Crohn's Disease (CD) Trial in Worldwide (ABT-494)

Active, not recruiting
  • Crohn's Disease (CD)
  • La Jolla, California
  • +60 more
Sep 8, 2022

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)

Active, not recruiting
  • Chronic Lymphoid Leukemia
  • Dresden, Germany
  • +16 more
Nov 8, 2022

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))

Not yet recruiting
  • Endometriosis
  • Moderate to Severe Endometriosis-associated Pain
  • BG2109 100mg
  • +5 more
  • (no location specified)
Jun 6, 2023

Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Infection
  • Compensated Cirrhosis
  • ABT-450/r/ABT-267, ABT-333
  • Ribavirin (RBV)
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +2 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021